Publication | Open Access

PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma

Neoadjuvant ImmunotherapyCancer ImmunosurveillanceOncologyEsophageal CancerMedicineImmune-suppressive MicroenvironmentImmunologyPathologyCancer BiologyTumor MicroenvironmentTumor Biology